Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank33
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-4.29M
↑ 28% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-5.94M
Historical baseline
PeriodValueYoY Change
TTM$-4.29M+66.7%
2025$-12.90M+28.1%
2024$-17.95M-98.1%
2023$-9.06M-326.3%
2022$-2.13M-183.3%
2021$-750000.00+48.1%
2020$-1.45M+73.3%
2019$-5.42M-81.7%
2018$-2.98M-19.0%
2017$-2.51M-